ASSOCIATION OF INTEGRASE, MATRIX, AND REVERSE-TRANSCRIPTASE ANTIGENS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH VIRAL NUCLEIC-ACIDS FOLLOWING ACUTE INFECTION

被引:373
|
作者
BUKRINSKY, MI
SHAROVA, N
MCDONALD, TL
PUSHKARSKAYA, T
TARPLEY, WG
STEVENSON, M
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PATHOL & MICROBIOL,600 S 42ND ST,OMAHA,NE 68198
[2] UPJOHN CO,CANCER & INFECT DIS RES,KALAMAZOO,MI 49001
关键词
PREINTEGRATION COMPLEX; NUCLEAR IMPORT;
D O I
10.1073/pnas.90.13.6125
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have examined components of the preintegration complex of human immunodeficiency virus type 1 (HIV-1) and have analyzed features which govern the association of these components. HIV-1 nucleoprotein complexes, isolated from nuclear and cytoplasmic extracts of CD4+ cells after acute virus infection, contained viral RNA and DNA in association with viral matrix (MA), integrase (IN), and reverse transcriptase (RT) antigens but not capsid (CA) antigens and possessed integration activity in vitro. Association of IN but not RT or MA antigens with viral DNA was detergent-stable. Analysis of viral DNA synthesis and nuclear import of viral nucleoprotein complexes in the presence of a reversible RT inhibitor demonstrated that reverse transcription of viral RNA could be completed entirely in the host cell nucleus. Our studies demonstrate structural and functional features of the nucleoprotein (preintegration) complex of HIV-1 which are pertinent to the understanding of early events in the lentiviral life cycle.
引用
收藏
页码:6125 / 6129
页数:5
相关论文
共 50 条
  • [21] THE EFFECTS OF CYSTEINE MUTATIONS ON THE CATALYTIC ACTIVITIES OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LOYA, S
    TAL, R
    HUGHES, SH
    HIZI, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (20) : 13879 - 13883
  • [22] INHIBITION OF HEAT INACTIVATION OF REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SEROPOSITIVE SERA
    NAGUMO, T
    TAKEUCHI, Y
    HOSHINO, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (06): : 594 - 600
  • [23] ANALYSIS OF MUTATIONS AT POSITION-184 IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOYER, PL
    HUGHES, SH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1624 - 1628
  • [24] HIGH-AFFINITY SSDNA INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS
    SCHNEIDER, DJ
    FEIGON, J
    HOSTOMSKY, Z
    GOLD, L
    BIOCHEMISTRY, 1995, 34 (29) : 9599 - 9610
  • [25] THE BINDING OF A NOVEL BISHETEROARYLPIPERAZINE MEDIATES INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    DUEWEKE, TJ
    KEZDY, FJ
    WASZAK, GA
    DEIBEL, MR
    TARPLEY, WG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (01) : 27 - 30
  • [26] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY 3'-BLOCKED OLIGONUCLEOTIDE PRIMERS
    AUSTERMANN, S
    KRUHOFFER, M
    GROSSE, F
    BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) : 2581 - 2589
  • [27] MUTATIONAL ANALYSIS OF RESIDUE-190 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    KLEIM, JP
    BENDER, R
    KIRSCH, R
    MEICHSNER, C
    PAESSENS, A
    RIESS, G
    VIROLOGY, 1994, 200 (02) : 696 - 701
  • [28] SPECIFIC-INHIBITION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND THE CHIMERIC ENZYMES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 BY NONNUCLEOSIDE INHIBITORS
    HIZI, A
    TAL, R
    SHAHARABANY, M
    CURRENS, MJ
    BOYD, MR
    HUGHES, SH
    MCMAHON, JB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1037 - 1042
  • [29] VIRAL RESISTANCE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC PYRIDINONE REVERSE-TRANSCRIPTASE INHIBITORS
    NUNBERG, JH
    SCHLEIF, WA
    BOOTS, EJ
    OBRIEN, JA
    QUINTERO, JC
    HOFFMAN, JM
    EMINI, EA
    GOLDMAN, ME
    JOURNAL OF VIROLOGY, 1991, 65 (09) : 4887 - 4892
  • [30] COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS
    BYRNES, VW
    SARDANA, VV
    SCHLEIF, WA
    CONDRA, JH
    WATERBURY, JA
    WOLFGANG, JA
    LONG, WJ
    SCHNEIDER, CL
    SCHLABACH, AJ
    WOLANSKI, BS
    GRAHAM, DJ
    GOTLIB, L
    RHODES, A
    TITUS, DL
    ROTH, E
    BLAHY, OM
    QUINTERO, JC
    STASZEWSKI, S
    EMINI, EA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1576 - 1579